128 related articles for article (PubMed ID: 32772757)
1. Aberrant TTF-1 Expression in Peripheral T-Cell Lymphomas: A Diagnostic Pitfall.
Chang ST; Chen SW; Chen BJ; Pan ST; Karube K; Chuang SS
Int J Surg Pathol; 2021 Apr; 29(2):165-168. PubMed ID: 32772757
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
[TBL] [Abstract][Full Text] [Related]
3. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters.
Hakim SA; Youssef NS
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H
Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783
[TBL] [Abstract][Full Text] [Related]
6. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.
Pratt D; Afsar N; Allgauer M; Fetsch P; Palisoc M; Pittaluga S; Quezado M
Clin Neuropathol; 2017; 36(6):263-271. PubMed ID: 28933335
[TBL] [Abstract][Full Text] [Related]
9. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917
[TBL] [Abstract][Full Text] [Related]
10. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):429-44. PubMed ID: 22531688
[TBL] [Abstract][Full Text] [Related]
11. Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system.
Kashima K; Hashimoto H; Nishida H; Arakane M; Yada N; Daa T; Yokoyama S
Appl Immunohistochem Mol Morphol; 2014; 22(2):119-24. PubMed ID: 23531851
[TBL] [Abstract][Full Text] [Related]
12. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
13. Thyroid transcription factor-1 promotes lymph node metastasis by inducing lymphangiogenesis in ovarian carcinoma.
Li M; Zheng W; Wei J; Hou C; Yang Y; Sun L; Wang C
Pathol Res Pract; 2017 Sep; 213(9):1054-1058. PubMed ID: 28843751
[TBL] [Abstract][Full Text] [Related]
14. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
15. TTF-1 expression in breast carcinoma: an unusual but real phenomenon.
Ni YB; Tsang JY; Shao MM; Chan SK; Tong J; To KF; Tse GM
Histopathology; 2014 Mar; 64(4):504-11. PubMed ID: 24111789
[TBL] [Abstract][Full Text] [Related]
16. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.
Hang JF; Hsu CY; Lin SC; Wu CC; Lee HJ; Ho DM
Mod Pathol; 2017 Mar; 30(3):318-328. PubMed ID: 27910945
[TBL] [Abstract][Full Text] [Related]
19. TTF-1 may not be a reliable marker for differentiating metastasis from brain tumors.
Unal B; Yildirim S; Sezer C; Süren D
Turk Patoloji Derg; 2014; 30(3):201-5. PubMed ID: 24913303
[TBL] [Abstract][Full Text] [Related]
20. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide.
Wen KW; Fakhri B; Menke J; Ruiz-Cordero R; Gill RM; Ohgami RS
Ann Diagn Pathol; 2020 Jun; 46():151534. PubMed ID: 32473554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]